These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9174949)

  • 1. Epitope contiguous chains and antibody recognition in HIV-1 synthetic peptide antigens.
    Aleanzi M; Perotti N; Montaner A; Lottersberger J; Tonarelli G; Marcipar A
    J Mol Recognit; 1996; 9(5-6):631-8. PubMed ID: 9174949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
    Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
    J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.
    Horal P; Svennerholm B; Jeansson S; Rymo L; Hall WW; Vahlne A
    J Virol; 1991 May; 65(5):2718-23. PubMed ID: 1707985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
    Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
    Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
    AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41.
    Cano A; Viveros M; Acero G; Govezensky T; Munguia ME; Gonzalez E; Soto L; Gevorkian G; Manoutcharian K
    Immunol Lett; 2004 Sep; 95(2):207-12. PubMed ID: 15388262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of complement-mediated inhibition of antibody binding to HIV gp41.
    Hidvégi T; Prohászka Z; Ujhelyi E; Thielens NM; Dierich MP; Hampl H; Arlaud G; Nagy K; Füst G
    Clin Exp Immunol; 1993 Dec; 94(3):490-3. PubMed ID: 8252810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection.
    Eberle J; Loussert-Ajaka I; Brust S; Zekeng L; Hauser PH; Kaptue L; Knapp S; Damond F; Saragosti S; Simon F; Gürtler LG
    J Virol Methods; 1997 Aug; 67(1):85-91. PubMed ID: 9274821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy.
    Oldstone MB; Tishon A; Lewicki H; Dyson HJ; Feher VA; Assa-Munt N; Wright PE
    J Virol; 1991 Apr; 65(4):1727-34. PubMed ID: 2002540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HIV-1 peptide presentation on the affinity constants of two monoclonal antibodies determined by BIAcore technology.
    Mani JC; Marchi V; Cucurou C
    Mol Immunol; 1994 Apr; 31(6):439-44. PubMed ID: 7514268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping of an immunodominant region of the transmembrane protein of the human immunodeficiency virus (HIV-1).
    Döpel SH; Porstmann T; Henklein P; von Baehr R
    J Virol Methods; 1989 Aug; 25(2):167-77. PubMed ID: 2476460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.
    Dorn J; Masciotra S; Yang C; Downing R; Biryahwaho B; Mastro TD; Nkengasong J; Pieniazek D; Rayfield MA; Hu DJ; Lal RB
    J Clin Microbiol; 2000 Feb; 38(2):773-80. PubMed ID: 10655384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collection of phage-peptide probes for HIV-1 immunodominant loop-epitope.
    Palacios-Rodríguez Y; Gazarian T; Rowley M; Majluf-Cruz A; Gazarian K
    J Microbiol Methods; 2007 Feb; 68(2):225-35. PubMed ID: 17046088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1).
    Neurath AR; Strick N; Jiang S
    Virology; 1992 May; 188(1):1-13. PubMed ID: 1373549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
    Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.
    Parekh BS; Pau CP; Kennedy MS; Dobbs TL; McDougal JS
    AIDS Res Hum Retroviruses; 2001 Jan; 17(2):137-46. PubMed ID: 11177393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational display of two neutralizing epitopes of HIV-1 gp41 on the Flock House virus capsid protein.
    Buratti E; Tisminetzky SG; Scodeller ES; Baralle FE
    J Immunol Methods; 1996 Oct; 197(1-2):7-18. PubMed ID: 8890890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing modified and plain peptide linked enzyme immunosorbent assay (ELISA) for detection of human immunodeficiency virus type-1 (HIV-1) and type-2 (HIV-2) antibodies.
    Manocha M; Chitralekha KT; Thakar M; Shashikiran D; Paranjape RS; Rao DN
    Immunol Lett; 2003 Feb; 85(3):275-8. PubMed ID: 12663143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.